US Patent Issued to EIRGEN PHARMA on Aug. 18 for "Methods and compositions for reducing parathyroid levels" (Canadian, American Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,629, issued on Aug. 18, was assigned to EIRGEN PHARMA LTD. (Waterford, Ireland).

"Methods and compositions for reducing parathyroid levels" was invented by Eric J. Messner (Lake Forest, Ill.), P. Martin Petkovich (Kingston, Canada), Jay A. White (Newmarket, Canada), Samir P. Tabash (Whitby, Canada), Joel Z. Melnick (Evanston, Ill.) and Charles W Bishop (Miami).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and compositions for reducing serum parathyroid levels in, for example, chronic kidney disease patients are disclosed. In these methods, an effective amount of a modified release formulation of 25-hydroxyvitamin D is orally administered to ...